[LGND] QoQ Quarter Result on 30-Sep-2011 [#Q3]

Stock
[LGND] Ligand Pharmaceuticals Incorporated
Announcement Date
08-Nov-2011
Financial Year
2011
Quarter
30-Sep-2011 [#Q3]
Profit Trend
QoQ- -327.35%
YoY- 67.02%
Quarter Report
LGND's Result
LGND's Financial Summary
View:
Show?
Quarter Result
30/06/12 31/03/12 31/12/11 30/09/11 30/06/11 31/03/11 31/12/10 CAGR
Revenue 5,742 5,636 12,936 5,741 7,463 3,896 3,940 28.57%
PBT -3,728 -522 5,997 -3,884 -773 -4,292 -1,587 76.80%
Tax 338 -35 495 22 141 -13,778 -3,935 -
NP -2,267 1,133 5,502 -3,906 -914 9,625 4,503 -
Tax Rate - - -8.25% - - - - -
Total Cost 8,009 4,503 7,434 9,647 8,377 -5,729 -563 -
Ratio Analysis
30/06/12 31/03/12 31/12/11 30/09/11 30/06/11 31/03/11 31/12/10 CAGR
NP Margin -39.48 20.10 42.53 -68.04 -12.25 247.05 114.29 -
Per Share
30/06/12 31/03/12 31/12/11 30/09/11 30/06/11 31/03/11 31/12/10 CAGR
EPS -0.11 0.07 0.28 -0.20 -0.05 0.49 0.23 -
EPS Diluted -0.11 0.07 0.28 -0.20 -0.05 0.49 0.23 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.